November 18, 2024

Supreme Court Blocks Xifaxan Generic Entry

Reuters

November 15, 2024

RFK Jr.'s Vision for U.S. Food and Drug System Reform

The FDA's nutrition department has to go: "They're not doing their job. They're not protecting our kids."

Reuters

November 15, 2024

RFK Jr to the FDA: 'Pack Your Bags'

"If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."

Reuters

November 12, 2024

FDA Denies Full Approval for Intercept’s Liver Drug

Reuters

November 08, 2024

FDA Approves Novel Combination for Gastric or Gastroesophageal Junction Adenocarcinoma

The U.S. Food and Drug Administration approved zolbetuximab-clzb (Vyloy), a claudin 18.2-directed cytolytic antibody, with fluoropyrimidine- and platinum-containing chemotherapy, for the first-line tr...

The ASCO Post

November 04, 2024

FTC Finalizes "Click-to-Cancel" Rule

FTC finalizes rule requiring subscription-based businesses to provide cancellation processes as simple as enrollment methods, effective 180 days after Federal Register publication.

Conexiant

November 04, 2024

Obesity Pill Safe in Early Trial, Drugmaker Reports

AstraZeneca's early-stage trial of an experimental weight-loss pill from Eccogene showed promise in safety and tolerability, paving the way for Phase II trials to reduce body weight in obese and overweight individuals.

Reuters

November 01, 2024

Novo's Weight-Loss Drug Improves Liver Fibrosis in Late-Stage Trial

Novo Nordisk's latest trial reveals positive effects of weight-loss drug on liver health, pointing to potential benefits beyond weight management. #LiverHealth #Semaglutide

Reuters

October 30, 2024

FDA Approves Lowest Dose of Novo’s Weight-Loss Drug

The availability of Novo Nordisk's Wegovy and diabetes drug Ozempic has improved, with all doses now listed as available on the U.S. health regulator's website.

Reuters